Patents by Inventor Myrna A. Monck

Myrna A. Monck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN
    Publication number: 20240043524
    Abstract: The present disclosure relates to pharmaceutical compositions comprising from about 100 mg to about 300 mg of an antigen binding protein which binds to IL-5. Compositions and antigen binding proteins of the invention are useful in the treatment of IL-5 mediated diseases, such as asthma, and can be administered about once every 6 months.
    Type: Application
    Filed: December 20, 2021
    Publication date: February 8, 2024
    Inventors: Daren J AUSTIN, Nicholas P BIRD, Myrna A MONCK, Isabelle J POULIQUEN, Melissa A SHUMAN
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20220380452
    Abstract: The present disclosure relates to compositions for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: August 5, 2022
    Publication date: December 1, 2022
    Inventors: Myrna A. MONCK, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11459384
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: October 4, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20220185878
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 16, 2022
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • Biopharmaceutical compositions
    Patent number: 11299541
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: April 12, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11286298
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: March 29, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11274148
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: March 15, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210340247
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210340246
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210332125
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: October 28, 2021
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions comprising interleukin-5 antibody
    Patent number: 10870695
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: December 22, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20200199219
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: March 2, 2020
    Publication date: June 25, 2020
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20180251539
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: August 22, 2016
    Publication date: September 6, 2018
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • FORMULATIONS WITH REDUCED VISCOSITY
    Publication number: 20140044727
    Abstract: The present invention is directed to a method for reducing the viscosity of a formulation containing acetate and a therapeutic protein and formulations made using the claimed method.
    Type: Application
    Filed: April 6, 2012
    Publication date: February 13, 2014
    Applicant: Glaxosmithkline LLC
    Inventors: Myrna A. Monck, Man Yi Wong, Kai Zhang
  • FORMULATIONS WITH REDUCED VISCOSITY
    Publication number: 20140023655
    Abstract: The present invention is directed to a method for reducing the viscosity of a formulation containing citrate and a therapeutic protein and formulations made using the claimed method.
    Type: Application
    Filed: April 6, 2012
    Publication date: January 23, 2014
    Applicant: Glaxosmithkline LLC
    Inventors: Myrna A. Monck, Man Yi Wong, Kai Zhang
  • Fusogenic liposomes
    Patent number: 7205273
    Abstract: The present invention relates to liposomes and virosomes and, more particularly, to liposomal and virosomal delivery systems for transporting materials such as drugs, nucleic acids and proteins.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: April 17, 2007
    Assignee: The University of British Columbia
    Inventors: Pieter R. Cullis, Lewis S. L. Choi, Myrna Monck, Austin Bailey
  • Receptor antagonist-lipid conjugates and delivery vehicles containing same
    Publication number: 20040013720
    Abstract: Disclosed are vesicular drug delivery vehicles, such as liposomes, comprising a targeting ligand which comprises a non-biological, biomitric antagonist to a receptor that is upregulated at a disease site.
    Type: Application
    Filed: April 25, 2003
    Publication date: January 22, 2004
    Inventors: Harma M. Ellens, Myrna A. Monck, Ping-Yang Yeh
  • Fusogenic liposomes
    Publication number: 20030125517
    Abstract: The present invention relates to liposomes and virosomes and, more particularly, to liposomal and virosomal delivery systems for transporting materials such as drugs, nucleic acids and proteins.
    Type: Application
    Filed: June 5, 2002
    Publication date: July 3, 2003
    Applicant: The University of British Columbia
    Inventors: Pieter R. Cullis, Lewis S.L. Choi, Myrna Monck, Austin L. Bailey
  • Fusogenic liposomes
    Patent number: 6417326
    Abstract: The present invention relates to liposomes and virosomes and, more particularly, to liposomal and virosomal delivery systems for transporting materials such as drugs, nucleic acids and proteins.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: July 9, 2002
    Assignee: The University of British Columbia
    Inventors: Pieter R. Cullis, Lewis S. L. Choi, Myrna Monck, Austin L. Bailey